Inventor · disambiguated record
Ali Fattom
Also filed as: FATTOM ALI · FATTOM ALI I · FATTOM ALI IBRAHIM
32 granted patents·18 pending applications·654 citations·filing 1984–2023
98Inventor score
Top patents by PatentIndex Score
50 records- 0193US7247502B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2004·Granted Jul 24, 2007·41 cites·2 claims
- 0293US6232082B1Hapten-carrier conjugates for treating and preventing nicotine addictionNABI·Filed 1998·Granted May 15, 2001·78 cites·41 claims
- 0392US6294177B1Staphylococcus aureus antigen-containing whole cell vaccineNABI·Filed 1999·Granted Sep 25, 2001·91 cites·26 claims
- 0491US7776620B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2007·Granted Aug 17, 2010·12 cites·5 claims
- 0588US7449189B2Glycoconjugate vaccines for use in immune-compromised populationsNABI BIOPHARMACEUTICALS·Filed 2006·Granted Nov 11, 2008·4 cites·18 claims
- 0688US7030101B2Compositions of β-glucans and specific antibodiesNABI BIOPHARMACEUTICALS·Filed 2002·Granted Apr 18, 2006·24 cites·24 claims
- 0787US6518031B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI·Filed 2001·Granted Feb 11, 2003·19 cites·18 claims
- 0885US7754225B2Method of protecting against staphylococcal infectionGLAXOSMITHKLINE BIOLOG SA·Filed 2006·Granted Jul 13, 2010·8 cites·11 claims
- 0981US9561271B2Nanoemulsion respiratory syncytial virus (RSV) subunit vaccineFATTOM ALI I·Filed 2012·Granted Feb 7, 2017·5 cites·26 claims
- 1081US9492525B2Human respiratory syncytial virus vaccineFATTOM ALI I·Filed 2012·Granted Nov 15, 2016·9 cites·25 claims
- 1181US8232072B2Smoking cessation kit and methodKALNIK MATTHEW·Filed 2009·Granted Jul 31, 2012·18 cites·18 claims
- 1281US5770208AStaphylococcus aureus B-linked hexosamine antigenNABI·Filed 1996·Granted Jun 23, 1998·67 cites·23 claims
- 1380US6355625B1Compositions of β-glucans and specific IGIVNABI·Filed 1999·Granted Mar 12, 2002·50 cites·24 claims
- 1480US5866140AType I surface antigen associated with staphylococcus epidermidisNABI·Filed 1994·Granted Feb 2, 1999·39 cites·10 claims
- 1578US11147869B2Herpes simplex virus nanoemulsion vaccineBLUEWILLOW BIOLOGICS INC·Filed 2018·Granted Oct 19, 2021·1 cites·28 claims
- 1678US6756361B1Enterococcus antigens and vaccinesNABI·Filed 1997·Granted Jun 29, 2004·47 cites·17 claims
- 1778US6537559B2Staphylococcus aureus antigen-containing whole cell vaccineNABI·Filed 2001·Granted Mar 25, 2003·6 cites·4 claims
- 1878US5250201APolymeric substance and method of separating and culturing bacteriaSOLMAT SYST·Filed 1991·Granted Oct 5, 1993·18 cites·4 claims
- 1977US8026109B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2010·Granted Sep 27, 2011·2 cites·3 claims
- 2077US6773891B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2002·Granted Aug 10, 2004·6 cites·2 claims
- 2176US6936258B1Staphylococcus antigen and vaccineNABI BIOPHARMACEUTICALS·Filed 1999·Granted Aug 30, 2005·33 cites·18 claims
- 2272US10596251B2Nanoemulsion respiratory syncytial virus (RSV) subunit vaccineNANOBIO CORP·Filed 2017·Granted Mar 24, 2020·1 cites·19 claims
- 2371US7531633B2Staphylococcus antibodiesNABI BIOPHARMACEUTICALS·Filed 2004·Granted May 12, 2009·4 cites·13 claims
- 2467US10206996B2Herpes simplex virus nanoemulsion vaccineFATTOM ALI I·Filed 2012·Granted Feb 19, 2019·1 cites·28 claims
- 2567US5961975AType I surface antigen associated with staphylococcus epidermidisNABI·Filed 1995·Granted Oct 5, 1999·23 cites·12 claims
- 2667US2023330202A1Nanoemulsion and methods of use thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2023·Application pending·0 cites
- 2766US7291343B2Enterococcus antigens and vaccinesNABI BIOPHARMACEUTICALS·Filed 2004·Granted Nov 6, 2007·1 cites·24 claims
- 2865US2022105172A1Herpes simplex virus nanoemulsion vaccines and methods of using the sameBLUEWILLOW BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 2961US2024058434A1Nanoemulsion universal influenza vaccineBLUEWILLOW BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 3059US11642405B2Nanoemulsion and methods of use thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2018·Granted May 9, 2023·0 cites·17 claims
- 3158US2011217320A1Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2011·Application pending·0 cites
- 3255US6194161B1Staphylococcus aureus antigenNABI·Filed 1998·Granted Feb 27, 2001·19 cites·20 claims
- 3354US2006134141A1Glycoconjugate vaccines containing peptidoglycanNABI BIOPHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 3453US2006153857A1Method of treating staphylococcus aureus infectionNABI BIOPHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 3552US4649110APolymeric substance, and method of separating and culturing bacteria to provide polymeric substance useful in liquid clarification and soil conditioningSOLMAT SYST·Filed 1984·Granted Mar 10, 1987·10 cites·13 claims
- 3650US4693842ACyanobacterium-produced bioemulsifier composition and solution thereofSOLMAT SYST·Filed 1985·Granted Sep 15, 1987·9 cites·8 claims
- 3749US2014093537A1Immunogenic compositions comprising nanoemulsion and methods of administering the sameBAKER JR JAMES R·Filed 2013·Application pending·0 cites
- 3847US2009053235A1Use of alpha-toxin for treating and preventing staphylococcus infectionsNABI BIOPHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 3947US2008131457A1Use of alpha-toxin for treating and preventing staphylococcus infectionsNABI BIOPHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 4046US2003113350A1Glycoconjugate vaccines for use in immune-compromised populationsFiled 2001·Application pending·0 cites
- 4146US2020138935A1Chlamydia nanoemulsion vaccineNANOBIO CORP·Filed 2018·Application pending·0 cites
- 4245US2006228368A1Method of protecting against staphylococcal infectionNABI BIOPHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 4342US2018221466A9Use of alpha-toxin for treating and preventing staphylococcus infectionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2012·Application pending·0 cites
- 4442US2020246449A1Intravenous immunoglobulin compositions specific for respiratory syncytial virus and methods of making and using the sameNANOBIO CORP·Filed 2018·Application pending·0 cites
- 4541US2011064750A1Method and kit for treating nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2010·Application pending·0 cites
- 4637US2009074755A1Use of panton-valentine leukocidin for treating and preventing staphylococcus infectionsNABI BIOPHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 4736US4894161AProcess for clarifying a liquid using a polymeric substanceSOLMAT SYST·Filed 1986·Granted Jan 16, 1990·7 cites·17 claims
- 4836US2011182918A1Personalized drug treatment and smoking cessation kit and methodNABI BIOPHARMACEUTICALS·Filed 2010·Application pending·0 cites
- 4936US2018071380A1Immunogenic compositions for use in vaccination against bordetellaUNIV MICHIGAN REGENTS·Filed 2016·Application pending·0 cites
- 5026US4826624ADispersing liquid hydrocarbon into a second liquidYISSUM RESEARCH DEV SOLMAT SYS·Filed 1987·Granted May 2, 1989·1 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Ali Fattom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →